about
HIV-1 Nef impairs MHC class II antigen presentation and surface expressionDeficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndromeB lymphocytes secrete antigen-presenting vesiclesSystematic microRNA analysis identifies ATP6V0C as an essential host factor for human cytomegalovirus replicationCell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell linesHuman immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinaseThe signal peptide of the IgE receptor alpha-chain prevents surface expression of an immunoreceptor tyrosine-based activation motif-free receptor pool.Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartmentsBoosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules.Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interactionExit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics.Quantitating MHC class II trafficking in primary dendritic cells using imaging flow cytometryRab 7: an important regulator of late endocytic membrane trafficIsoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartmentsProtein targeting by tyrosine- and di-leucine-based signals: evidence for distinct saturable componentsDirect pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transportIi chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes.Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes.Inhibition of invariant chain (Ii)-calnexin interaction results in enhanced degradation of Ii but does not prevent the assembly of alpha beta Ii complexesA structural transition in class II major histocompatibility complex proteins at mildly acidic pH.Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation.A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments.Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing.Abundant empty class II MHC molecules on the surface of immature dendritic cells.Competition model for upregulation of the major histocompatibility complex class II-associated invariant chain by human immunodeficiency virus type 1 NefEarly endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulationCD1c molecules broadly survey the endocytic systemMHC class II antigen presentation by dendritic cells regulated through endosomal sorting.Invariant Chain Complexes and Clusters as Platforms for MIF Signaling.Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells.Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartmentsThe biogenesis of the MHC class II compartment in human I-cell disease B lymphoblasts.Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump.The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface.Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas.
P2860
Q22248080-B8A1D7DF-4168-458A-9B20-57EA9983E17EQ24320302-76E310B1-9C67-4605-9B0E-0383EED22950Q24678522-9C3F9B79-3535-4F21-8FF5-2D465500D833Q28538007-CF0379E1-06CE-42B8-9565-6FC915FA1E60Q28611880-A6A73E04-ACBF-40E4-9EB7-ED7CD63A3E25Q33763110-73994630-B6E4-40D4-A21B-EE7CCC0F1538Q33832396-ED725C8C-FCCD-484E-9CB0-B1D5B6C5AE2AQ33833534-8499EDE5-E12C-4881-ABBE-11E10DB3702DQ34422852-1EAEE136-3D78-40AF-B68D-B31454328C96Q34665662-BEA87DFF-C1EB-41F4-8DEA-76C747AAB55CQ35589680-8286564A-FD1C-49F9-B575-75492CC476AAQ35788191-14FFD2E3-86E2-4AE1-8445-A8C0922B042AQ35856359-9AED06DE-0145-4780-A85A-5F69431977CAQ35908490-BFCA90AA-E36B-4455-865F-75EFF2EBD5E4Q36236377-595F9BF4-3A7C-4B3F-ABA5-BB212D00285EQ36236708-46EBD3AB-5EF5-4310-B48E-470872E86A16Q36237576-7959568A-C0DA-4885-85C7-40C32C225A42Q36255884-39F4BCC2-6687-4E5E-90DE-E1F08C29E479Q36274077-852E27B1-8834-43C0-90AB-72F6AD514BBDQ36365285-C73F459E-A2A1-463F-9CE7-51216BB9C50AQ36365643-3FCF0B04-3FC0-464E-AB4B-EF4DFFA04A2EQ36366080-429E3057-B218-4F9A-A0D9-C36BB537EB59Q36376556-99A7C783-F70A-4651-868F-3125FB908913Q36382769-E4388784-54CE-4AC2-A9CC-12C2E1B0007BQ36498133-0FB4F6F3-DCF5-4B4C-BBBD-F8790EE40D97Q36733819-D99EA381-1B0C-49A4-981A-F1826FEB3309Q36780413-8F535026-36E4-4764-9B67-01427BBE65AAQ36845640-447CE6B4-8781-4823-ACA1-855177070A12Q36907651-4A045C42-8B56-4645-9DA7-15A68CDAA36BQ36949900-E76D7D0F-95F3-42DB-84D2-02A622136E23Q37228343-809959C2-70F3-4874-8EEE-677765103442Q38167996-9593F87B-8B7A-4EDA-9145-EC71FE560A44Q39139156-53BF4E05-C2C3-4DD9-9331-13DD513E9089Q39832869-A72D7A96-8C03-49C6-BEB9-0CFF4D9470E7Q41082969-A0996C2C-2550-4DF3-BA5C-E0F15CB0512CQ41225461-4A7BBA6F-A3BC-4074-8EEC-4518CC7253FFQ41317185-3D40491F-E735-4072-AA06-F2302BEC0FCAQ41829565-5D8A6F23-3E82-489E-93BE-384B40BA7B16Q41952493-E3252590-EB63-49D5-8071-3B11426EF57C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1995
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How MHC class II molecules reach the endocytic pathway.
@en
How MHC class II molecules reach the endocytic pathway.
@nl
type
label
How MHC class II molecules reach the endocytic pathway.
@en
How MHC class II molecules reach the endocytic pathway.
@nl
prefLabel
How MHC class II molecules reach the endocytic pathway.
@en
How MHC class II molecules reach the endocytic pathway.
@nl
P2093
P2860
P1433
P1476
How MHC class II molecules reach the endocytic pathway.
@en
P2093
H L Ploegh
P Bénaroch
P2860
P407
P577
1995-01-01T00:00:00Z